Trestle Biotherapeutics

Winter 2021Active

Bioengineered kidneys for patients with kidney failure

Save

Winter 2021Active

Bioengineered kidneys for patients with kidney failure

Save

Company details

We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.

Location

San Diego, CA, USA

Founded

Unknown

Request the Trestle Biotherapeutics report.

Trestle Biotherapeutics has no report yet. Sign in with your email to request one.